MTX-241F

N/A

Report date: 2022/12/28 17:24:43
NME

Base Information

Drug NameMTX-241F
Drug Alias NameMTX-241F
ClassificationSmall molecules
Mechanisms of ActionApoptosis stimulantsDNA-dependent protein kinase inhibitorsEpidermal growth factor receptor erbB1 antagonists +[4] 
TargetsDNA-dependent protein kinaseEpidermal growth factor receptor erbB1Phosphatidylinositol 3 kinase alpha
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Michigan
Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A